Global Nifedipine Market Research Report 2020

Publisher Name :
Date: 07-Feb-2020
No. of pages: 93
Inquire Before Buying

This report focuses on Nifedipine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nifedipine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Bayer (Germany)

- Actavis (USA)

- Teva (Israel)

- Pfizer (USA)

- Shyndec (China)

- Honglin (China)

- Huanghai (China)

- Yabao (China)

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Nifedipine Controlled Release Tablets

- Nifedipine Extended Action Tablets

Segment by Application

- Primary Pulmonary Hypertension

- Heart Failure

- Others

Global Nifedipine Market Research Report 2020

Table of Contents
1 Nifedipine Market Overview
1.1 Product Overview and Scope of Nifedipine
1.2 Nifedipine Segment by Type
1.2.1 Global Nifedipine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Nifedipine Controlled Release Tablets
1.2.3 Nifedipine Extended Action Tablets
1.3 Nifedipine Segment by Application
1.3.1 Nifedipine Sales Comparison by Application: 2020 VS 2026
1.3.2 Primary Pulmonary Hypertension
1.3.3 Heart Failure
1.3.4 Others
1.4 Global Nifedipine Market Size Estimates and Forecasts
1.4.1 Global Nifedipine Revenue 2015-2026
1.4.2 Global Nifedipine Sales 2015-2026
1.4.3 Nifedipine Market Size by Region: 2020 Versus 2026
2 Global Nifedipine Market Competition by Manufacturers
2.1 Global Nifedipine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nifedipine Revenue Share by Manufacturers (2015-2020)
2.3 Global Nifedipine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nifedipine Manufacturing Sites, Area Served, Product Type
2.5 Nifedipine Market Competitive Situation and Trends
2.5.1 Nifedipine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nifedipine Players (Opinion Leaders)
3 Nifedipine Retrospective Market Scenario by Region
3.1 Global Nifedipine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nifedipine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nifedipine Market Facts & Figures by Country
3.3.1 North America Nifedipine Sales by Country
3.3.2 North America Nifedipine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nifedipine Market Facts & Figures by Country
3.4.1 Europe Nifedipine Sales by Country
3.4.2 Europe Nifedipine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nifedipine Market Facts & Figures by Region
3.5.1 Asia Pacific Nifedipine Sales by Region
3.5.2 Asia Pacific Nifedipine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nifedipine Market Facts & Figures by Country
3.6.1 Latin America Nifedipine Sales by Country
3.6.2 Latin America Nifedipine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Nifedipine Market Facts & Figures by Country
3.7.1 Middle East and Africa Nifedipine Sales by Country
3.7.2 Middle East and Africa Nifedipine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nifedipine Historic Market Analysis by Type
4.1 Global Nifedipine Sales Market Share by Type (2015-2020)
4.2 Global Nifedipine Revenue Market Share by Type (2015-2020)
4.3 Global Nifedipine Price Market Share by Type (2015-2020)
4.4 Global Nifedipine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Nifedipine Historic Market Analysis by Application
5.1 Global Nifedipine Sales Market Share by Application (2015-2020)
5.2 Global Nifedipine Revenue Market Share by Application (2015-2020)
5.3 Global Nifedipine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Nifedipine Business
6.1 Bayer (Germany)
6.1.1 Corporation Information
6.1.2 Bayer (Germany) Description, Business Overview and Total Revenue
6.1.3 Bayer (Germany) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bayer (Germany) Products Offered
6.1.5 Bayer (Germany) Recent Development
6.2 Actavis (USA)
6.2.1 Actavis (USA) Nifedipine Production Sites and Area Served
6.2.2 Actavis (USA) Description, Business Overview and Total Revenue
6.2.3 Actavis (USA) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Actavis (USA) Products Offered
6.2.5 Actavis (USA) Recent Development
6.3 Teva (Israel)
6.3.1 Teva (Israel) Nifedipine Production Sites and Area Served
6.3.2 Teva (Israel) Description, Business Overview and Total Revenue
6.3.3 Teva (Israel) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Teva (Israel) Products Offered
6.3.5 Teva (Israel) Recent Development
6.4 Pfizer (USA)
6.4.1 Pfizer (USA) Nifedipine Production Sites and Area Served
6.4.2 Pfizer (USA) Description, Business Overview and Total Revenue
6.4.3 Pfizer (USA) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer (USA) Products Offered
6.4.5 Pfizer (USA) Recent Development
6.5 Shyndec (China)
6.5.1 Shyndec (China) Nifedipine Production Sites and Area Served
6.5.2 Shyndec (China) Description, Business Overview and Total Revenue
6.5.3 Shyndec (China) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Shyndec (China) Products Offered
6.5.5 Shyndec (China) Recent Development
6.6 Honglin (China)
6.6.1 Honglin (China) Nifedipine Production Sites and Area Served
6.6.2 Honglin (China) Description, Business Overview and Total Revenue
6.6.3 Honglin (China) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Honglin (China) Products Offered
6.6.5 Honglin (China) Recent Development
6.7 Huanghai (China)
6.6.1 Huanghai (China) Nifedipine Production Sites and Area Served
6.6.2 Huanghai (China) Description, Business Overview and Total Revenue
6.6.3 Huanghai (China) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Huanghai (China) Products Offered
6.7.5 Huanghai (China) Recent Development
6.8 Yabao (China)
6.8.1 Yabao (China) Nifedipine Production Sites and Area Served
6.8.2 Yabao (China) Description, Business Overview and Total Revenue
6.8.3 Yabao (China) Nifedipine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Yabao (China) Products Offered
6.8.5 Yabao (China) Recent Development
7 Nifedipine Manufacturing Cost Analysis
7.1 Nifedipine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nifedipine
7.4 Nifedipine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nifedipine Distributors List
8.3 Nifedipine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Nifedipine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nifedipine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nifedipine by Type (2021-2026)
10.2 Nifedipine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nifedipine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nifedipine by Application (2021-2026)
10.3 Nifedipine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nifedipine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nifedipine by Region (2021-2026)
10.4 North America Nifedipine Estimates and Projections (2021-2026)
10.5 Europe Nifedipine Estimates and Projections (2021-2026)
10.6 Asia Pacific Nifedipine Estimates and Projections (2021-2026)
10.7 Latin America Nifedipine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nifedipine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Nifedipine Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Nifedipine Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Nifedipine Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Nifedipine Manufacturers Covered in This Study
Table 5. Global Nifedipine Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Nifedipine Sales Share by Manufacturers (2015-2020)
Table 7. Global Nifedipine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Nifedipine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Nifedipine Average Price (USD/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Nifedipine Sales Sites and Area Served
Table 11. Manufacturers Nifedipine Product Types
Table 12. Global Nifedipine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nifedipine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nifedipine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Nifedipine Players
Table 16. Global Nifedipine Sales (MT) by Region (2015-2020)
Table 17. Global Nifedipine Sales Market Share by Region (2015-2020)
Table 18. Global Nifedipine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Nifedipine Revenue Market Share by Region (2015-2020)
Table 20. North America Nifedipine Sales by Country (2015-2020) (MT)
Table 21. North America Nifedipine Sales Market Share by Country (2015-2020)
Table 22. North America Nifedipine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Nifedipine Revenue Market Share by Country (2015-2020)
Table 24. Europe Nifedipine Sales by Country (2015-2020) (MT)
Table 25. Europe Nifedipine Sales Market Share by Country (2015-2020)
Table 26. Europe Nifedipine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Nifedipine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Nifedipine Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Nifedipine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Nifedipine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Nifedipine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Nifedipine Sales by Country (2015-2020) (MT)
Table 33. Latin America Nifedipine Sales Market Share by Country (2015-2020)
Table 34. Latin America Nifedipine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Nifedipine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Nifedipine Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Nifedipine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Nifedipine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Nifedipine Revenue Market Share by Country (2015-2020)
Table 40. Global Nifedipine Sales (MT) by Type (2015-2020)
Table 41. Global Nifedipine Sales Share by Type (2015-2020)
Table 42. Global Nifedipine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Nifedipine Revenue Share by Type (2015-2020)
Table 44. Global Nifedipine Price (USD/Kg) by Type (2015-2020)
Table 45. Global Nifedipine Sales (MT) by Application (2015-2020)
Table 46. Global Nifedipine Sales Market Share by Application (2015-2020)
Table 47. Global Nifedipine Sales Growth Rate by Application (2015-2020)
Table 48. Bayer (Germany) Nifedipine Corporation Information
Table 49. Bayer (Germany) Description and Business Overview
Table 50. Bayer (Germany) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 51. Bayer (Germany) Main Product
Table 52. Bayer (Germany) Recent Development
Table 53. Actavis (USA) Nifedipine Corporation Information
Table 54. Actavis (USA) Corporation Information
Table 55. Actavis (USA) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 56. Actavis (USA) Main Product
Table 57. Actavis (USA) Recent Development
Table 58. Teva (Israel) Nifedipine Corporation Information
Table 59. Teva (Israel) Corporation Information
Table 60. Teva (Israel) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 61. Teva (Israel) Main Product
Table 62. Teva (Israel) Recent Development
Table 63. Pfizer (USA) Nifedipine Corporation Information
Table 64. Pfizer (USA) Corporation Information
Table 65. Pfizer (USA) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 66. Pfizer (USA) Main Product
Table 67. Pfizer (USA) Recent Development
Table 68. Shyndec (China) Nifedipine Corporation Information
Table 69. Shyndec (China) Corporation Information
Table 70. Shyndec (China) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 71. Shyndec (China) Main Product
Table 72. Shyndec (China) Recent Development
Table 73. Honglin (China) Nifedipine Corporation Information
Table 74. Honglin (China) Corporation Information
Table 75. Honglin (China) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Honglin (China) Main Product
Table 77. Honglin (China) Recent Development
Table 78. Huanghai (China) Nifedipine Corporation Information
Table 79. Huanghai (China) Corporation Information
Table 80. Huanghai (China) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. Huanghai (China) Main Product
Table 82. Huanghai (China) Recent Development
Table 83. Yabao (China) Nifedipine Corporation Information
Table 84. Yabao (China) Corporation Information
Table 85. Yabao (China) Nifedipine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Yabao (China) Main Product
Table 87. Yabao (China) Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Nifedipine Distributors List
Table 91. Nifedipine Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Nifedipine Sales (MT) Forecast by Type (2021-2026)
Table 96. Global Nifedipine Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Nifedipine Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Nifedipine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Nifedipine Sales (MT) Forecast by Application (2021-2026)
Table 100. Global Nifedipine Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Nifedipine Sales (MT) Forecast by Region (2021-2026)
Table 102. Global Nifedipine Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Nifedipine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Nifedipine Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Nifedipine
Figure 2. Global Nifedipine Sales Market Share by Type: 2020 VS 2026
Figure 3. Nifedipine Controlled Release Tablets Product Picture
Figure 4. Nifedipine Extended Action Tablets Product Picture
Figure 5. Global Nifedipine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Primary Pulmonary Hypertension
Figure 7. Heart Failure
Figure 8. Others
Figure 9. Global Nifedipine Market Size 2015-2026 (US$ Million)
Figure 10. Global Nifedipine Sales Capacity (MT) (2015-2026)
Figure 11. Global Nifedipine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Nifedipine Sales Share by Manufacturers in 2020
Figure 13. Global Nifedipine Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Nifedipine Revenue in 2019
Figure 15. Nifedipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Nifedipine Sales Market Share by Region (2015-2020)
Figure 17. Global Nifedipine Sales Market Share by Region in 2019
Figure 18. Global Nifedipine Revenue Market Share by Region (2015-2020)
Figure 19. Global Nifedipine Revenue Market Share by Region in 2019
Figure 20. North America Nifedipine Sales Market Share by Country in 2019
Figure 21. North America Nifedipine Revenue Market Share by Country in 2019
Figure 22. U.S. Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 23. U.S. Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 25. Canada Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Nifedipine Sales Market Share by Country in 2019
Figure 27. Europe Nifedipine Revenue Market Share by Country in 2019
Figure 28. Germany Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 29. Germany Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 31. France Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 33. U.K. Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 35. Italy Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 37. Russia Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Nifedipine Sales Market Share by Region in 2019
Figure 39. Asia Pacific Nifedipine Revenue Market Share by Region in 2019
Figure 40. China Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 41. China Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 43. Japan Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 45. South Korea Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 47. India Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 49. Australia Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 51. Taiwan Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 53. Indonesia Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 55. Thailand Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 57. Malaysia Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 59. Philippines Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 61. Vietnam Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Nifedipine Sales Market Share by Country in 2019
Figure 63. Latin America Nifedipine Revenue Market Share by Country in 2019
Figure 64. Mexico Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 65. Mexico Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 67. Brazil Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 69. Argentina Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Nifedipine Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Nifedipine Revenue Market Share by Country in 2019
Figure 72. Turkey Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 73. Turkey Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 75. Saudi Arabia Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Nifedipine Sales Growth Rate (2015-2020) (MT)
Figure 77. U.A.E Nifedipine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Nifedipine by Type (2015-2020)
Figure 79. Sales Market Share of Nifedipine by Type in 2019
Figure 80. Revenue Share of Nifedipine by Type (2015-2020)
Figure 81. Revenue Market Share of Nifedipine by Type in 2019
Figure 82. Global Nifedipine Sales Growth by Type (2015-2020) (MT)
Figure 83. Global Nifedipine Sales Market Share by Application (2015-2020)
Figure 84. Global Nifedipine Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Nifedipine by Application (2015-2020)
Figure 86. Global Revenue Share of Nifedipine by Application in 2020
Figure 87. Bayer (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Actavis (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Teva (Israel) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Pfizer (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Shyndec (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Honglin (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Huanghai (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Yabao (China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Price Trend of Key Raw Materials
Figure 96. Manufacturing Cost Structure of Nifedipine
Figure 97. Manufacturing Process Analysis of Nifedipine
Figure 98. Nifedipine Industrial Chain Analysis
Figure 99. Channels of Distribution
Figure 100. Distributors Profiles
Figure 101. Porter's Five Forces Analysis
Figure 102. North America Nifedipine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 103. North America Nifedipine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Nifedipine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Nifedipine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Nifedipine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Nifedipine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Nifedipine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Nifedipine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Nifedipine Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Nifedipine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs